---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-25-275971"
form_type: "8-K"
ticker: "XOMA"
cik: "0000791908"
company_name: "XOMA Royalty Corp"
filed_at: "2025-11-12T23:59:59+00:00"
generated_at: "2026-05-16T21:57:58.082621+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# XOMA Royalty Q3 net income $14.1M vs loss $17.2M; revenue $9.4M; cash receipts $43.9M YTD

## Summary
- Net income of $14.1M in Q3 2025, compared to net loss of $17.2M in Q3 2024.
- Revenue $9.4M (Q3) and $38.4M (9M), up from $7.2M and $19.8M in prior-year periods.
- Cash receipts from partners: $14.3M in Q3; $43.9M in first nine months of 2025.
- Recorded $17.9M gain on HilleVax acquisition and $1.8M gain on Turnstone in Q3.
- Cash and equivalents $130.6M at Sept 30; repurchased ~108,510 shares for $2.4M YTD.

## SEC filing metadata
- accession: 0001193125-25-275971
- form_type: 8-K
- ticker: XOMA
- cik: 0000791908
- company_name: XOMA Royalty Corp
- filed_at: 2025-11-12T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/791908/000119312525275971/0001193125-25-275971-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/791908/000119312525275971/d35634d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-25-275971
- JSON: https://secwatch.observer/filing/0001193125-25-275971.json
- Plain text: https://secwatch.observer/filing/0001193125-25-275971.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.